TY  - GEN
AU  - Sandmann,Frank G
AU  - Franken,Margreet G
AU  - Steenhoek,Adri
AU  - Koopmanschap,Marc A
TI  - Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over time
SN  - 1872-6054
PY  - 2014///0826
KW  - Adalimumab
KW  - Anti-Inflammatory Agents
KW  - economics
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Benzamides
KW  - Decision Making
KW  - Drug Costs
KW  - statistics & numerical data
KW  - Economics, Pharmaceutical
KW  - Evidence-Based Practice
KW  - Filgrastim
KW  - Granulocyte Colony-Stimulating Factor
KW  - Health Expenditures
KW  - Humans
KW  - Imatinib Mesylate
KW  - Insurance, Health, Reimbursement
KW  - Netherlands
KW  - Piperazines
KW  - Polyethylene Glycols
KW  - Pyrimidines
KW  - Recombinant Proteins
KW  - Reimbursement Mechanisms
KW  - Uncertainty
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.healthpol.2013.03.006
ER  -